My
MyoKardia (BMS)
S San Francisco CAFounded 2012150 employees
Private CapbiotechAcquiredCardiology
Platform: Camzyos HCM
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Voxatapinarof | MYO-3328 | Phase 2 | 1 | PARP | LNOvarian Ca | ||
| MYO-1420 | MYO-1420 | Preclinical | 1 | Menin | CLL |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (2)